Consolidation Prevention and Competition Promotion Act of 2021
Official title: A bill to reform the antitrust laws to better protect competition in the American economy, to amend the Clayton Act to modify the standard for an unlawful acquisition.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on the Judiciary.
Consolidation Prevention and Competition Promotion Act of 2021
This bill revises antitrust laws applicable to mergers and anticompetitive conduct.
Specifically, the bill applies a stricter standard for permissible mergers by prohibiting mergers that (1) create an appreciable risk of materially lessening competition, or (2) unfairly lower the prices of goods or wages because of a lack of competition among buyers or employers (i.e., a monopsony). Under current law, mergers that substantially lessen competition are prohibited.
Additionally, for some large mergers or mergers that concentrate markets beyond a certain threshold, the bill shifts the burden of proof to the merging parties to prove that the merger does not violate the law.
The bill also establishes within the Federal Trade Commission (FTC) the Office of the Competition Advocate.
The Government Accountability Office must report on (1) the success of merger remedies required by the Department of Justice or the FTC in recent consent decrees; and (2) the impact of mergers and acquisitions on wages, employment, innovation, and new business formation.
- Introduced in Senate Formatted Text PDF Formatted XML
- MILLER STRATEGIES, LLC
- ALZHEIMER'S ASSOCIATION
- UNIFIED SOLUTIONS, LLC
- HEALTHCARE LEADERSHIP COUNCIL
- HEALTHCARE LEADERSHIP COUNCIL
- ALZHEIMER'S ASSOCIATION
Bodies those filers lobbied
- HOUSE OF REPRESENTATIVES
- SENATE
- Health & Human Services, Dept of (HHS)
- Centers For Medicare and Medicaid Services (CMS)
- Centers For Disease Control & Prevention (CDC)
- Federal Emergency Management Agency (FEMA)
- Food & Drug Administration (FDA)
- Government Accountability Office (GAO)
Cite this page
U.S. Congress. (2026). S. 3267: Consolidation Prevention and Competition Promotion Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-3267/
"S. 3267: Consolidation Prevention and Competition Promotion Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-3267/.
S. 3267, 117th Cong. (2026), https://openamerica.io/bill/117-S-3267/.
[S. 3267: Consolidation Prevention and Competition Promotion Act of 2021](https://openamerica.io/bill/117-S-3267/)